Previous studies have largely focused on tumor cell-intrinsic effects, such as targeting SPHK1 to inhibit S1P synthesis or enhancing SGPL1 to degrade S1P, with the aim of suppressing tumor proliferation (15). The gene discussed is SPHK1; the disease is neoplasm.